New: Twisting applicator for Sof’Bag by Nemera

The dermal application of potent gel or cream drugs can be problematic when rubbing is done with the hands. A comprehensive hand washing after application is thus compulsory to avoid any unwanted body area (or other persons) to be in contact with the active formulation.

With Nemera’s integrated twisting applicator a dose of formulation is released in a cup and can then be applied and rubbed with a soft touch applicator on the targeted area. Hand contact with the drug is then avoided.

This applicator comes with a Sof’Bag® airless technology composed of an aluminum pouch inside a rigid bottle which allows a high protection of the formulation as the pouch is tight to moisture, light or oxygen as well as an evacuation rate above 95% to help limiting overfilling.

This device is ideal for dermal or transdermal drugs like those for hormone replacement therapies, pain treatment or psoriasis and eczema.

Do not hesitate to contact us for more information: information@nemera.net.

See also

Nemera's RetroNose enhances therapeutic efficacy of nasal treatments

The number of applications through the nasal route is expanding, either for local treatments (e.g. chronic rhinosinusitis) or for systemic treatments (e.g. migraine, etc.). The clinical efficacy of a nasal treatment depends on how it is deposited in the nose, because the pharmaceutical target (local, systemic, brain) is directly related to a specific nasal anatomical site. That’s why Nemera has collaborated with CEPR to develop a different and portable delivery technology called RetroNose for a better drug deposition in the distal region of the nose, without lung deposition.

e-Novelia wins the ‘Excellence in Pharma: Drug Delivery Devices’ award at CPhI Worldwide 2018

On October 9th, during the CPhI Pharma Awards Gala, e-Novelia®, Nemera’s electronic add-on for ophthalmic droppers, was celebrated as the best-in-class innovation displayed at the show for “Excellence in Pharma: Drug Delivery Devices”. e-Novelia®, Nemera’s smart ophthalmic add-on, has been designed to make patients’ life easier, by offering increased comfort and optimized adherence to their treatments.

Safelia 1ml and 2.25ml autoinjectors designed to be patient and syringe friendly

Nemera’s new generation 2-step autoinjector platforms are suitable for fluid to highly viscous injections. Safelia® has been designed to ease patient self-injection experience and to deliver even the most challenging drugs (viscous formulations up to several Centipoise, sustain released, concentrated, fragile and shear sensitive formulations, either in subcutaneous or intramuscular layers, on two platforms: up to 1ml or up to 2.25ml delivery).

  • Isabel Thomas
  • Product Info
  • English
  • Created 15 Oct 2018
  • Modified 28 Feb 2019
  • Hits 762